Form4insider filings, from the source

SEC Form 4 · accession 0001354488-17-000385

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jr. John L. Armstrong
Officer — Exec VP of Tech Operations
Period of report
Mar 1, 2017
Accepted (ET)
Mar 2, 2017 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy Common Stock)F1$2.18Mar 1, 2017A100,000A—Mar 1, 2027Common Stock100,000100,000D
Restricted Stock UnitsF2—holding————Feb 28, 2027Common Stock36,05736,057D
Stock Option (Right to Buy Common Stock)F3$1.52holding————Nov 14, 2024Common Stock10,00010,000D
Stock Option (Right to Buy Common Stock)F4$3.25holding————Jul 28, 2025default15,00015,000D
Stock Option (Right to Buy Common Stock)F5$2.51holding————Mar 8, 2026Common Stock200,000200,000D

Explanation of responses